Connor, Clark & Lunn Investment Management (CC&L)’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42M Buy
1,639,358
+1,182,018
+258% +$27.8M 0.08% 217
2026
Q1
$6.84M Buy
+457,340
New +$7.8M 0.02% 591
2025
Q4
Sell
-19,828
Closed -$356K 1578
2025
Q3
$356K Buy
+19,828
New +$291K ﹤0.01% 1326

Other funds holding CORZ

Connor, Clark & Lunn Investment Management (CC&L)'s CORZ Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Core Scientific (CORZ) stake by 258% in Q2 2026, buying an estimated $27.8M and bringing the position to 1,639,358 shares worth $42M. The position accounts for 0.08% of the portfolio, ranked #217.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CORZ in Q3 2025 and has held it in 3 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 1,639,358 shares of Core Scientific worth $42M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) bought 1,182,018 Core Scientific shares in Q2 2026, an estimated $27.8M.
  • Core Scientific made up 0.08% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #217 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Core Scientific in Q3 2025 and has held it in 3 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.